Asst/Assoc Prof of Med (Hematology/Oncology)-Phase I Experimental Therapeutics Clinical Investigator
Reported by 40 physicians · region cohort · total comp, not the employer's posted pay
Overview
- Location
- New Brunswick, New Jersey
- SalaryDr Signal range
- $409k – $546k
- Practice
- Academic Medical Center · Cancer Center
40 physician reports · not the employer's posted pay
Role summary
Rutgers Cancer Institute and RWJBarnabas Health seek a medical oncologist or hematologist for a Phase I Experimental Therapeutics Program at an NCI-Designated Comprehensive Cancer Center. The role combines early-phase clinical trial conduct and development with disease-specific clinical practice on the Clinical Scholar faculty track, with 0.6 clinical FTE and mentoring responsibilities.
What the posting highlights
- Patient population: Cancer patients in early-phase clinical trials
- Research or clinical-trial participation is noted
- Teaching or an academic practice setting is noted
- APP collaboration or supervision is noted
SalaryDr summary based on the original posting
Posted base pay vs physician-reported total comp
Physician-reported range shown; the employer did not post pay for this role.
Compensation
- What physicians report
- $409k – $546k
- Pay context
- SalaryDr Signal · physician-reported
- Report sample
- 40 recent physician reports · region cohort
- Compensation basis
- Estimated total compensation
Benefits named in the posting
- Startup support and research infrastructure provided for clinical trial development
This is a SalaryDr Signal computed from 40 recent, approved physician reports (region cohort). It is not an employer offer or posted pay; this employer did not disclose pay.
Employer
Rutgers Cancer Institute
Claim this free profile to see who's viewing your roles and manage your listings.
Facility & Community
- Practice setting
- Academic Medical Center
- Facility type
- Cancer Center
- Patient population
- Cancer patients in early-phase clinical trials
- EHR
- Not stated in posting
SalaryDr will show local peer compensation and hiring supply here once this role has enough physician-reported data.
Questions to ask the employer
- What is the call schedule, and is call compensated separately or built into the base?
- At 0.6 FTE, how do compensation, benefits, and call scale — and is moving to 1.0 FTE an option later?
- How many weeks of PTO and CME time are included, and is unused time paid out?
Generated from this posting's disclosed facts and the SalaryDr comparison — bring them to the first recruiter call.
Work Design
- FTE
- 0.6
- Teaching
- Yes
- Research
- Yes
- Supervises APPs
- Yes
Visa & Eligibility
- Remote
- No
Source & Verification
- Source
- Aggregated (ym_careers)
- Salary label
- SalaryDr Signal
- First seen
- 1 wk ago
- Last verified
- yesterday
- Extraction confidence
- 65%
Full description
Rutgers Cancer Institute and RWJBarnabas Health seek an academically oriented medical oncologist or hematologist to join and help grow our Phase 1 Experimental Therapeutics Program . The successful candidate will play a key role in the design, conduct, and expansion of early-phase clinical trials while increasing patient access to innovative cancer therapies at New Jersey's only NCI-Designated Comprehensive Cancer Center and across the RWJBarnabas Health system. Candidates with an interest in Phase I trial development and translational research are encouraged to apply . Disease specialization is flexible and will be aligned with the successful candidate's clinical and research interests with opportunities to maintain and grow a disease-specific practice while participating in a robust early-phase therapeutics program. Opportunity Highlights Conduct and develop early-phase clinical trials, including first-in-human, targeted therapy, immuno-oncology, and combination studies. Ensure protocol adherence and compliance with ICH-GCP, FDA regulations (21 CFR), IRB requirements, and institutional SOPs . Author and review protocols, informed consent documents, abstracts, and manuscripts. Interpret and integrate pharmacokinetic (PK), pharmacodynamic (PD), and correlative/biomarker data into clinical decision-making. Collaborate with sponsors, CROs, translational scientists, pharmacists, and research coordinators to advance study conduct and portfolio growth. Contribute to feasibility assessments, site selection, for new early-phase trials and expand access throughout the RWJBarnabas Health network. Mentor students, housestaff, fellows, and junior faculty, and research staff. Startup support and research infrastructure will be provided to facilitate clinical trial development and academic growth. The successful candidate will join the faculty of Rutgers Robert Wood Johnson Medical School on the Clinical Scholar track, with approximately 0.6 clinical FTE dedicated to supporting both academic and clinical priorities. Clinical practice will be located in the Jack & Sheryl Morris Cancer Center , a state-of-the-art, freestanding cancer hospital designed to advance cancer research and patient care through multidisciplinary collaboration. Candidate Qualifications MD or equivalent degree Completed or completing an accredited Hematology/Oncology fellowship program Board Certified or Board Eligible in Medical Oncology and/or Hematology Eligible for or currently holding a New Jersey medical license Demonstrated interest and experience in clinical research Experience in Phase I or early-phase clinical trials is preferred